Trademark Overview
On Wednesday, April 17, 2024, a trademark application was filed for EVEXTABIO with the United States Patent and Trademark Office. The USPTO has given the EVEXTABIO trademark a serial number of 79397616. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Monday, May 12, 2025. This trademark is owned by EVEXTA BIO. The EVEXTABIO trademark is filed in the Pharmaceutical Products category with the following description:
Medicines for the treatment of cancer; anti-cancer medicines; autonomic medicines for medical use for the treatment of cancer, as well as gynecological, obstetric, mammary, digestive, neurological and cerebral diseases, disorders and conditions in women; medicines for human and animal medicine for the treatment of cancer, as well as gynecological, obstetric, mammary, digestive, neurological and cerebral diseases, disorders and conditions in women; pharmaceutical and biological medical preparations and compositions for cancer treatment; pharmaceutical and biological medical preparations and compositions for use in human and animal health for cancer treatment; pharmaceutical and biological preparations and compositions for medical use for treatment of gynecological, obstetric, mammary, digestive, neurological and cerebral diseases, disorders and conditions; pharmaceutical and biological medical preparations and compositions for medical use for treatment of gynecological, obstetric, mamma...
